American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 938-945 , December 2007

The Effect of Age, Sex, and Race on Urinary Markers of Kidney Damage in Children

  • Felicia Trachtenberg, PhD

      Affiliations

    • New England Research Institutes, Watertown, MA
    • Corresponding Author InformationAddress correspondence to Felicia Trachtenberg, PhD, New England Research Institutes, 9 Galen St, Watertown, MA 02472.
  • ,
  • Lars Barregård, MD, PhD

      Affiliations

    • Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital and Academy, Göteborg, Sweden.

Received 11 April 2007 ,Accepted 23 August 2007.

References 

  1. World Health Organization (WHO). Concise International Chemical Assessment Document 50 (Elemental Mercury and Inorganic Mercury Compounds: Human Health Aspects). Geneva, Switzerland: WHO; 2003;
  2. Cardenas A, Roels H, Bernard AM, et al. Markers of early renal changes induced by industrial pollutants (I. Application to workers exposed to mercury vapour). Br J Ind Med. 1993;50:17–27
  3. Bakker AJ. Detection of microalbuminuria (Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration). Diabetes Care. 1999;22:307–313
  4. Harvey JN, Hood K, Platts JK, Devarajoo S, Meadows PA. Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care. 1999;22:1597–1598
  5. Jacobs DR, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens (The Coronary Artery Risk Development in Young Adults Study). Am J Epidemiol. 2002;155:1114–1119
  6. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445–459
  7. Tencer J, Thysell H, Grubb A. Analysis of proteinuria: Reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha1-antitrypsin. Scand J Clin Lab Invest. 1996;56:691–700
  8. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol. 2002;13:1034–1039
  9. Lehrnbecher T, Greissinger S, Navid F, Pfuller H, Jeschke R. Albumin, IgG, retinol-binding protein, and alpha1-microglobulin excretion in childhood. Pediatr Nephrol. 1998;12:290–292
  10. Skinner AM, Addison GM, Price DA. Changes in the urinary excretion of creatinine, albumin and N-acetyl-beta-d-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr. 1996;155:596–602
  11. Jung K, Hempel A, Grutzmann KD, Hempel RD, Schreiber G. Age-dependent excretion of alanine aminopeptidase, alkaline phosphatase, gamma-glutamyltransferase and N-acetyl-beta-d-glucosaminidase in human urine. Enzyme. 1990;43:10–16
  12. Agirbasli M, Radhakrishnamurthy B, Jiang X, Bao W, Berenson GS. Urinary N-acetyl-beta-d-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population (The Bogalusa Heart Study). Am J Hypertens. 1996;9:157–161
  13. Lakatua DJ, Blomquist CH, Haus E, Sackett-Lundeen L, Berg H, Swoyer J. Circadian rhythm in urinary N-acetyl-beta-glucosaminidase (NAG) of clinically healthy subjects (Timing and phase relation to other urinary circadian rhythms). Am J Clin Pathol. 1982;78:69–77
  14. James GD, Sealey JE, Alderman M, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects (Race, sex, and age differences). Am J Hypertens. 1988;1:124–131
  15. Kesteloot H, Joossens JV. On the determinants of the creatinine clearance (A population study). J Hum Hypertens. 1996;10:245–249
  16. Remer T, Neubert A, Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr. 2002;75:561–569
  17. Vestbo E, Damsgaard EM, Froland A, Mogensen CE. Urinary albumin excretion in a population based cohort. Diabet Med. 1995;12:488–493
  18. Hjorth L, Helin I, Grubb A. Age-related reference limits for urine levels of albumin, orosomucoid, immunoglobulin G and protein HC in children. Scand J Clin Lab Invest. 2000;60:65–73
  19. Davies AG, Postlethwaite RJ, Price DA, Burn JL, Houlton CA, Fielding BA. Urinary albumin excretion in school children. Arch Dis Child. 1984;59:625–630
  20. Chelliah R, Sagnella GA, Markandu ND, MacGregor GA. Urinary protein and essential hypertension in black and in white people. Hypertension. 2002;39:1064–1070
  21. Lindeman RD, Romero L, Liang HC, et al. Prevalence of proteinuria/microalbuminuria in an elderly urban, biethnic community. Geriatr Nephrol Urol. 1998;8:123–130
  22. Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Bao W, Berenson GS. Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population (The Bogalusa Heart Study). Am J Hypertens. 1994;7:794–800
  23. Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ. Microalbuminuria in a middle-aged workforce (Effect of hyperglycemia and ethnicity). Diabetes Care. 1993;16:1485–1493
  24. Houser MT. The effects of age and urine concentration on lysozyme and N-acetyl-beta-d-glucosaminidase (NAG) content in urine. Ann Clin Biochem. 1986;23:297–302
  25. Oba K, Hirai M, Ajiro Y, et al. Effect of age on urinary excretion of N-acetyl-beta-d-glucosaminidase. Nippon Ika Daigaku Zasshi. 1999;66:33–36
  26. Osborne J. Urinary excretion of N-acetyl-beta-d-glucosaminidase in children. Arch Dis Child. 1980;55:719–721
  27. Jung K, Pergande M. Sex- and age-dependent reference values of alpha-1-microglobulin in urine. Nephron. 1992;62:474–475
  28. Bellinger DC, Trachtenberg F, Barregard L, et al. Neuropsychological and renal effects of dental amalgam in children: A randomized clinical trial. JAMA. 2006;295:1775–1783
  29. The Children’s Amalgam Trial: Design and methods. Control Clin Trials. 2003;24:795–814
  30. Jarup L, Hellstrom L, Alfven T, et al. Low level exposure to cadmium and early kidney damage (The OSCAR study). Occup Environ Med. 2000;57:668–672
  31. Schultz CJ, Dalton RN, Turner C, Neil HA, Dunger DB The Oxford Regional Prospective Study Group. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. Diabet Med. 2000;17:7–14
  32. Matteucci E, Gregori G, Pellegrini L, Navalesi R, Giampietro O. Effects of storage time and temperature on urinary enzymes. Clin Chem. 1991;37:1436–1441
  33. Loeb WF, Das SR, Trout JR. The effect of erythritol on the stability of gamma-glutamyl transpeptidase and N-acetyl glucosaminidase in human urine. Toxicol Pathol. 1997;25:264–267
  34. Manley SE, Burton ME, Fisher KE, Cull CA, Turner RC. Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at −20 degrees C. Clin Chem. 1992;38:2294–2299
  35. Klasen IS, Reichert LJ, de Kat Angelino CM, Wetzels JF. Quantitative determination of low and high molecular weight proteins in human urine: influence of temperature and storage time. Clin Chem. 1999;45:430–432
  36. Green LW. Manual for scoring socioeconomic status for research on health behavior. Public Health Rep. 1970;85:815–827
  37. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098
  38. Lam TK, Leung DT. More on simplified calculation of body-surface area. N Engl J Med. 1988;318:1130
  39. Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications. 1998;12:43–60
  40. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE). Pediatrics. 2000;105:1242–1249
  41. Basturk T, Altuntas Y, Kurklu A, Aydin L, Eren N, Unsal A. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Ren Fail. 2006;28:125–128

 Originally published online as doi:10.1053/j.ajkd.2007.08.014 on October 30, 2007.

PII: S0272-6386(07)01235-8

doi: 10.1053/j.ajkd.2007.08.014

American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 938-945 , December 2007